From pathogenesis to new developments in treatment of primary progressive multiple sclerosis. Literature review
Multiple sclerosis (MS) is characterised as a chronic autoimmune inflammatory disease of the central nervous system (CNS) affecting more than 2.3 million people all over the world. Approximately 15% of all MS cases are manifesting as primary progressive MS (PPMS). Inflammation has long been thought...
Saved in:
Main Authors: | A. Juknelytė, Ž. Vaičekauskytė, D. Mickevičienė, R. Balnytė |
---|---|
Format: | Article |
Language: | English |
Published: |
Vilnius University Press
2020-03-01
|
Series: | Neurologijos seminarai |
Subjects: | |
Online Access: | https://www.journals.vu.lt/neurologijos_seminarai/article/view/27759 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of microglia in the pathogenesis of multiple sclerosis and links to immunomodulatory therapy
by: P. Valiukevičius, et al.
Published: (2023-10-01) -
Ocrelizumab-induced colitis—critical review and case series from a Romanian cohort of MS patients
by: Ileana Maria Vodă, et al.
Published: (2025-02-01) -
Adherence to disease modifying therapies in patients with multiple sclerosis
by: D. Pileckė, et al.
Published: (2019-06-01) -
Treatment of Multiple Sclerosis with Cladribine Tablets: Literature Review and the Guidance of the Lithuanian Association of Neurologists
by: R. Kizlaitienė, et al.
Published: (2024-03-01) -
Optic neuritis and multiple sclerosis association
by: L. Matukynaitė, et al.
Published: (2020-09-01)